HOME >> MEDICINE >> NEWS
Pregnancy, not high-risk behavior, predictor of STD testing among newly homeless youth

In the first study of its kind focusing on newly homeless youth, UCLA researchers have found that high-risk sexual behavior did not predict whether these youths were tested for sexually transmitted diseases. Instead, they were tested only when someone became pregnant or got someone pregnant.

The findings, to be published in the May issue of the peer-reviewed journal AIDS and Behavior and available online at http://dx.doi.org/10.1007/s10461-005-9044-8, indicate that there is an urgent need for outreach programs targeting sexually active homeless youths -- who are at particularly elevated risk for becoming infected with the human immunodeficiency virus (HIV) -- for early STD screening.

Contracting an STD can predispose one to becoming infected with the deadly virus that leads to acquired immunodeficiency syndrome (AIDS), said Dr. Rosa Solorio, assistant professor of family medicine at the David Geffen School of Medicine at UCLA and the study's lead researcher. Some of these infections do not present symptoms and these youths may not be aware of the need for testing, despite the high rates of STDs among them.

"We have to screen these youths to prevent a more negative outcome like HIV," Solorio said. "They need timely STD detection and treatment, and what the study shows is that the kids who are at highest risk are not getting tested."

The researchers surveyed 261 homeless youth who were aged 12 to 20, had been away from home at least two nights but less than six months and, if under age 17, were away from home without their parents' or guardians' permission or had been kicked out of the house. They were interviewed over 12 months between 2001 and 2002. The subjects were selected from 17 shelters and drop-in centers and 13 street hangout sites throughout Los Angeles County. Of those surveyed, half had been sexually active in the previous three months.

The researchers found
'"/>

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles
17-Feb-2006


Page: 1 2

Related medicine news :

1. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
2. Adolescents with high-risk sexual attitudes attract peers with similar attitudes
3. Percutaneous aortic valve replacement safe, successful in high-risk patients
4. Rhode Island Hospital study identifies high-risk patient populations for MRSA carriage
5. Alcohol interventions that teach practical skills work best with high-risk university students
6. Alcohol and high-risk sexual behaviors in Botswana
7. Drug could prevent type 2 diabetes in high-risk individuals
8. New HIV study identifies high-risk subgroups of adolescents
9. Use of breast MRI can be cost-effective for some women at high-risk of breast cancer
10. Doctors able to predict recurrence of high-risk breast cancers
11. Mammography does not increase risk of breast cancer in high-risk women

Post Your Comments:
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately held ... infections, microbial biofilms, and chronic wounds, announced that Dr. ... , Dr. Sinskey is a Professor ... of Technology, or MIT. He has been a member ... holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Two sisters ... and heart damage. Ilina and Medha Krishen use ... for sounds of trouble in breathing patterns or heartbeats. ... School in Michigan, wanted to find a way to ... air pollutants. Using an electronic stethoscope, Ilina recorded one ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... 20, 2014 The newly updated Worldwide ... of thousands of facts, figures and forecasts on the ... medical sector forecast categories the Worldwide Medical Market ... and national views on the worldwide medical market to ... report gives you data for 2010-2019, covering each country ...
(Date:10/20/2014)... October 20, 2014 The Advocator ... booth at the American Foundation for Suicide Prevention’s (AFSP) ... AFSP is a not-for-profit organization that hosts hundreds of ... from these events are used to help understand and ... and personal relationships as well. , The Advocator ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3
(Date:10/22/2014)... October 22, 2014 Oramed ... a clinical-stage pharmaceutical company focused on the development ... top-line clinical results from its Phase IIa clinical ... capsules, to treat type 1 diabetes. The trial was ... under a U.S. Food and Drug Administration ...
(Date:10/22/2014)... Colo. , Oct. 22, 2014   Surefire ... of infusion systems designed to maximize targeted delivery of ... pleased to announce that oncologist John R. Daniels ... Comprehensive Cancer Center, and surgical oncologist Steven C. ... have joined the Company,s Scientific Advisory Board (SAB).    ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
Cached News: